Scott D. Kelley

No open positions remaining

67 year

Health Technology

Consumer Services

Profile

Scott D.
Kelley served as Vice President & Medical Director at Aspect Medical Systems, Inc. from 2000 to 2011.
Prior to that, he was an Associate Professor & Director-Liver Transplant at The University of California, San Francisco from 1990 to 2000.
He also served as Chief Medical Officer at Flexion Therapeutics, Inc. from 2017 to 2021.
In addition, he held a position as Vice President-Medical Affairs at Sanofi Corp.
Dr. Kelley received his undergraduate and graduate degrees from Stanford University and his doctorate from The University of California, San Francisco in 1984.

Former positions of Scott D. Kelley

Companies	Position	End
FLEXION THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	2021-05-30
The University of California, San Francisco The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	1999-12-31
Sanofi Corp. Sanofi Corp. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Sanofi Corp. is a biopharmaceutical company dedicated to improving health outcomes through innovative medicines, vaccines, and patient-centered care. The company is based in Bridgewater, NJ. The company offers a broad portfolio including prescription medicines across therapeutic areas such as immunology, neurology, oncology, rare diseases, cardiovascular disease, diabetes, and transplant, alongside an extensive range of vaccines protecting against infectious diseases like influenza, respiratory syncytial virus (RSV), dengue, and COVID-19. Sanofi emphasizes scientific innovation with a robust R&D pipeline comprising clinical-stage projects, including advanced therapies like bispecific antibodies, gene therapies, and mRNA vaccines. The company addresses complex conditions such as chronic graft-versus-host disease in transplant patients and rare blood disorders like immune thrombocytopenia purpura, having launched therapies in these areas. Sanofi collaborates with healthcare professionals, patient communities, advocacy groups, and governments to expand access, promote holistic care, and advance science. Social impact initiatives focus on health equity, inclusion, environmental factors affecting respiratory health, and responsible business practices. Sanofi provides resources for healthcare providers and patients, including prescribing information, patient support, and educational materials, and maintains transparent communication through media channels and regular updates on financial performance, regulatory approvals, and clinical trial progress.	Corporate Officer/Principal	-
Aspect Medical Systems, Inc. Aspect Medical Systems, Inc. Medical SpecialtiesHealth Technology Develops anesthesia monitoring system	Chief Tech/Sci/R&D Officer	-

See the detail of Scott D. Kelley's experience

Training of Scott D. Kelley

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Scott D. Kelley's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Aspect Medical Systems, Inc. Aspect Medical Systems, Inc. Medical SpecialtiesHealth Technology Develops anesthesia monitoring system	Health Technology
Flexion Therapeutics, Inc. Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of patients with musculoskeletal conditions	Health Technology
Stanford University Stanford University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
The University of California, San Francisco The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Sanofi Corp. Sanofi Corp. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Sanofi Corp. is a biopharmaceutical company dedicated to improving health outcomes through innovative medicines, vaccines, and patient-centered care. The company is based in Bridgewater, NJ. The company offers a broad portfolio including prescription medicines across therapeutic areas such as immunology, neurology, oncology, rare diseases, cardiovascular disease, diabetes, and transplant, alongside an extensive range of vaccines protecting against infectious diseases like influenza, respiratory syncytial virus (RSV), dengue, and COVID-19. Sanofi emphasizes scientific innovation with a robust R&D pipeline comprising clinical-stage projects, including advanced therapies like bispecific antibodies, gene therapies, and mRNA vaccines. The company addresses complex conditions such as chronic graft-versus-host disease in transplant patients and rare blood disorders like immune thrombocytopenia purpura, having launched therapies in these areas. Sanofi collaborates with healthcare professionals, patient communities, advocacy groups, and governments to expand access, promote holistic care, and advance science. Social impact initiatives focus on health equity, inclusion, environmental factors affecting respiratory health, and responsible business practices. Sanofi provides resources for healthcare providers and patients, including prescribing information, patient support, and educational materials, and maintains transparent communication through media channels and regular updates on financial performance, regulatory approvals, and clinical trial progress.	Health Technology